DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Lebozec K, Jandrot-Perrus M, Avenard G, Favre-Bulle O, Billiald P.
Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: a case study prior to pharmaceutical development.
N Biotechnol 2018;
44: 31-40
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.